'''Aphrodisiac''' ya iku dat kang ngundhakaké libido nalika dikonsumsi. Aphrodisiacs iku béda karo dat-dat kang ana hubungane karo prakara-prakara fertilitas (kesuburan) kaya ta impotensi utawa dhisfungsi sèksual kapindho kaya ta dhisfungsi ereksi (ED).
Istilah iki dijupuk saka [[Basa Yunani|Greek]] ἀφροδισιακόν, ''aphrodisiakon'', i.e. "sèksual, aphrodisiac", saka ''aphrodisios'', i.e. "ana hubungane karo [[Afrodit|Aphrodite]]",<ref>[http://www.perseus.tufts.edu/hopper/text?doc=Perseus:text:1999.04.0057:entry=*)afrodisiako/s <span lang="grc">ἀφροδισιακόν</span>]<span>. </span></ref><ref>{{Cite web|title=aphrodisiac|url=http://www.etymonline.com/index.php?term=aphrodisiac&allowed_in_frame=0|publisher=[[Online Etymology Dictionary]]}}</ref> Dewi Asmaraning Yunani.
== Teksiraning Kwalitété Aphrodisiac ==
Saturut sujarah, akèh jinising panganan, inuman, lan kelakuan-kelakuan kang duwé réputasi kang bisa gawé cumbana luwih nyandhak lan/utawa nyenengaké. Nanging, saka panemu ngélmiah lan sujarah, kasiyat-kasiyat iku mau mungkin mung kapercayan kang mangan / ngombé manawa barang-barang iku mau mujarab ([[Plasebo|éfék plasébo]]). Perlu dicathet manawa akèh usada kang dilaporké bisa marahi libido ing kaanan kang ora temtu utawa idiopatis: ngundhakaké utawa mudhunaké kekarep sacumbananné wong gumantung marang kaanan subyék iku mau. Bab iki banjur marai prosès teksirané iku mau dadi angél. Contoné, Bupropion (Wellbutrin) uga kaloka minangka obat anti-depressant kang bisa netralaké éfék kang mudhunaké libido saka obat liyané kang diresépaké dokter. Nanging, amarga Wellbutrin mung ngundhakaké libido ing kadadéan mirunggan kang sadurungé uwis cacat déning obat-obat liya, obat iki adaté ora kagolong minangka sawiji aphrodisiac.
== Conto-conto Aphrodisiacs ==
=== Testosteron ===
Libido iku cetha ana gayutané karo tataraning hormon seks, mligi testosteron.<ref>{{Cite journal|title=The effects of testosterone on the cavernous tissue and erectile function|author=R. Shabsigh|year=1997|journal=World J. Urol|pmid=9066090|volume=15|pages=21–6|doi=10.1007/BF01275152|issue=1}}</ref> Nalika kasrat cumbana suda kedadéan ing sawiji uwong kang tataran testosteroné<ref>{{Cite journal|title=Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women.|first=Rebecca|last=Goldstat|author2=Esther Briganti|author3=Jane Tran|author4=Rory Wolfe|author5=Susan R. Davis|journal=Menopause|volume=10|issue=5|pages=390–8|date=September 2003|pmid=14501599|doi=10.1097/01.GME.0000060256.03945.20}}</ref> cendhèk (e.g., ibu-ibu sawisé menopause utawa bapak-bapak kang umuré punjul 60 taun 60<ref>{{Cite journal|title=Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men|year=2005|journal=J Clin Endocrinol Metab.|first=P.B.|last=Gray|author2=A.B. Singh|author3=L.J. Woodhouse|author4=T.W. Storer|author5=R. Casaburi|author6=J. Dzekov|author7=C. Dzekov|author8=I. Sinha-Hikim|author9=S. Bhasin|pmid=15827094|volume=90|issue=7|pages=3838–46|doi=10.1210/jc.2005-0247}}</ref>), suplemen-suplemen testosteron asringé bisa ngundhakaké libido. Pendekatan nganggo using sawénéh ''precursors'' kang niyaté ngundhakaké tataran testosteron uwis diarani éféktif kanggo bapak-bapak kang uwis tuwa,<ref>{{Cite journal|doi=10.1024/0300-9831.71.5.293|title=Effects of androstenedione-herbal supplementation on serum sex hormone concentrations in 30- to 59-year-old men|pmid=11725694|first=G.A.|last=Brown|author2=Vukovich MD|author3=Martini ER|author4=Kohut ML|author5=Franke WD|author6=Jackson DA|author7=King DS.|year=2001|journal=Int J Vitam Nutr Res|volume=71|issue=5|pages=293–301}}</ref> nanging ora bisa ngasilaké hal kang padha nalika ditéske marang golongan liya.<ref>{{Cite journal|title=Effects of anabolic precursors on serum testosterone concentrations and adaptations to resistance training in young men.|first=G.A.|last=Brown|author2=Vukovich MD|author3=Reifenrath TA|author4=Uhl NL|author5=Parsons KA|author6=Sharp RL|author7=King DS.|year=2000|journal=Int J Sport Nutr Exerc Metab|pmid=10997957|volume=10|issue=3|pages=340–59}}</ref>
